15 Apr 2026

SP Angel Healthcare Conditions

Poolbeg Pharma PLC (POLB:LON), 4.5 | Coiled Therapeutics Plc (COIL:LON), 8.0 | Proteome Sciences plc (PRM:LON), 2.1

- Vadim Alexandre | Greg Pave
- 4 pages

Proteome Sciences plc (AIM: PRM)*: 2025 Full year resultsCoiled Therapeutics plc (AIM: COIL)*: Presentation at the 18th Annual World Cancer Congress, Athens, Greece.Poolbeg Pharma plc (AIM: POLB): MHRA CTA granted & US payer research validates commercial opportunity

Sign up to access

Get access to our full offering from over 100 providers

Get access to our full offering from over 100 providers

SP Angel Healthcare Conditions

Poolbeg Pharma PLC (POLB:LON), 4.5 | Coiled Therapeutics Plc (COIL:LON), 8.0 | Proteome Sciences plc (PRM:LON), 2.1

Published: 15 Apr 2026
Author: Vadim Alexandre | Greg Pave
Pages: 4

Proteome Sciences plc (AIM: PRM)*: 2025 Full year resultsCoiled Therapeutics plc (AIM: COIL)*: Presentation at the 18th Annual World Cancer Congress, Athens, Greece.Poolbeg Pharma plc (AIM: POLB): MHRA CTA granted & US payer research validates commercial opportunity

Top